324 filings
Page 4 of 17
8-K
6mkqznrkn0e8kpfb
7 Jan 19
Insmed Provides Update on ARIKAYCE® (amikacin liposome inhalation suspension) U.S. Launch and Outlines Strategic Priorities for 2019
8:00am
8-K
doy1nguc7di 2l0w
8 Nov 18
Insmed Announces Changes to its Board of Directors
8:36am
8-K
neye5
30 Oct 18
Insmed Reports Third Quarter 2018 Financial Results and Provides Business Update
7:31am
8-K
w22c66gvck3ugfe
1 Oct 18
Regulation FD Disclosure
12:00am
8-K
56sse
17 Sep 18
Entry into a Material Definitive Agreement
12:00am
8-K
7hc6oxmmxh8em49u07l
2 Aug 18
Insmed Reports Second Quarter 2018 Financial Results and Provides Business Update
7:31am
8-K
uc65eqpt
17 May 18
Insmed Appoints Leo Lee to its Board of Directors
4:11pm
8-K
fdur9cw0p52k
16 May 18
Insmed Announces FDA Acceptance for Filing of New Drug Application for ALIS in NTM Lung Disease Caused by MAC
8:05am
8-K
wevj4b4m5gg
2 May 18
Insmed Reports First Quarter 2018 Financial Results and Provides Business Update
7:30am
8-K
lxjdo
29 Mar 18
Regulation FD Disclosure
12:00am
8-K
6j9mx2sv
23 Feb 18
Insmed Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update
12:00am
8-K
i5gkw1mlqvw c0rqir
14 Feb 18
Regulation FD Disclosure
12:00am
8-K
njemflgk323wf2 ldu
26 Jan 18
Insmed Announces Closing of Public Offering
12:00am
8-K
sm17zm03vk0v4
26 Jan 18
Insmed Announces Proposed Public Offering of Convertible Senior Notes
12:00am
8-K
ugqu7 5wwwmtez89k7
3 Jan 18
Regulation FD Disclosure
12:00am
8-K
j2okpwukdg21hz6vyz
2 Nov 17
Insmed Reports Third Quarter 2017 Financial Results and Provides Business Update
12:00am
8-K
0hcv6rakk
11 Sep 17
Insmed Announces Proposed Public Offering of Common Stock
12:00am
8-K
6a6a6cipebj
11 Sep 17
Insmed Announces Closing of Public Offering
12:00am
8-K
fwqpuccy
5 Sep 17
Regulation FD Disclosure
12:00am
8-K
n9e6bom
3 Aug 17
Insmed Reports Second Quarter 2017 Financial Results and Provides Business Update
12:00am